Background: LncRNA is a kind of non-coding RNA and its research is more popular in recent years, which has more than 200 nucleotides. It plays a significant part in various biological functions, including chromosome modification, genome modification, transcriptional activation, transcriptional interference, and other processes. FTX, at the center of the X chromosome inactivation and it has been shown that lncRNA FTX regulates cancer cells' development, migration, and invasion in many studies.
Methods: Relevant literature was collected through the PubMed system search and is summarized in this article.
Results: LncRNA FTX abnormally increased in tumor cells, such as liver cancer, stomach cancer, leukemia, renal cell carcinoma, colorectal cancer, glioma, osteosarcoma, etc. However, the expression level decreased in temporal lobe epilepsy, liver cirrhosis, heart failure, etc. Conclusion: FTX may be an important regulatory factor and a potential therapeutic target in cancers.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1381612826666201029164036 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
DNMT1-Dependent DNA Methylation of lncRNA FTX Inhibits the Ferroptosis of Hepatocellular Carcinoma.
Crit Rev Eukaryot Gene Expr
December 2024
Article Synopsis
- Hepatocellular carcinoma (HCC) is a highly aggressive tumor, and long non-coding RNAs (lncRNAs) play a significant role in its development, particularly the lncRNA FTX.
- The study found that FTX is less active in HCC patients, leading to poorer outcomes, and that its expression is reduced due to DNA methylation by DNMT1.
- Enhancing FTX levels triggers cell death (ferroptosis) in HCC cells by regulating the miR-374b-3p/TFRC pathway, suggesting the DNMT1/FTX/miR-374b-3p/TFRC pathway could be a promising target for new therapies in HCC
Current and future perspectives on the regulation and functions of miR-545 in cancer development.
Cancer Pathog Ther
July 2024
Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, China.
Micro ribonucleic acids (miRNAs) are a highly conserved class of single-stranded non-coding RNAs. Within the miR-545/374a cluster, miR-545 resides in the intron of the long non-coding RNA (lncRNA) on Xq13.2.
View Article and Find Full Text PDFRelationship of lncRNA FTX and miR-186-5p levels with diabetic peripheral neuropathy in type 2 diabetes and its bioinformatics analysis.
Ir J Med Sci
October 2024
Department of Function (Electroencephalogram Room), The Second People's Hospital of Liaocheng, Liaocheng, 252600, China.
Background: Diabetic peripheral neuropathy (DPN) frequently occurs as a secondary condition in individuals with type 2 diabetes mellitus (T2DM).
Objective: To explore the relationship of lncRNA FTX and miR-186-5p levels with DPN in T2DM.
Methods: The study enrolled 50 patients with T2DM and 45 patients with DPN.
Loss of One X and the Y Chromosome Changes the Configuration of the X Inactivation Center in the Genus Tokudaia.
Cytogenet Genome Res
August 2024
Reproductive and Developmental Science, Biosystems Science Course, Graduate School of Life Science, Hokkaido University, Sapporo, Japan.
Introduction: X chromosome inactivation (XCI) is an essential mechanism for dosage compensation between females and males in mammals. In females, XCI is controlled by a complex, conserved locus termed the X inactivation center (Xic), in which the lncRNA Xist is the key regulator. However, little is known about the Xic in species with unusual sex chromosomes.
View Article and Find Full Text PDFTranscriptomics analysis of long non-coding RNAs in smooth muscle cells from patients with peripheral artery disease and diabetes mellitus.
Sci Rep
April 2024
Experimental Vascular Surgery/Department of Vascular Surgery, University Hospital Zurich/University of Zurich, Schlieren, Switzerland.
Diabetes mellitus (DM) is a significant risk factor for peripheral arterial disease (PAD), and PAD is an independent predictor of cardiovascular disorders (CVDs). Growing evidence suggests that long non-coding RNAs (lncRNAs) significantly contribute to disease development and underlying complications, particularly affecting smooth muscle cells (SMCs). So far, no study has focused on transcriptome analysis of lncRNAs in PAD patients with and without DM.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!